...
首页> 外文期刊>Japanese Journal of Pharmacology >PHARMACOLOGICAL STUDIES OF LYCORENINE, AN ALKALOID OF LYCORIS RADIATA HERB.: II. EFFECTS OF BLOOD PRESSURE IN RATS AND DOGS AND THE MECHANISM OF TACHYPHYLAXIS TO THE VASODEPRESSOR ACTION OF LYCORENINE IN RATS
【24h】

PHARMACOLOGICAL STUDIES OF LYCORENINE, AN ALKALOID OF LYCORIS RADIATA HERB.: II. EFFECTS OF BLOOD PRESSURE IN RATS AND DOGS AND THE MECHANISM OF TACHYPHYLAXIS TO THE VASODEPRESSOR ACTION OF LYCORENINE IN RATS

机译:番石榴碱的生物碱番石榴碱的药理研究:II。大鼠和狗的血压变化和虎杖的机理对大鼠肾上腺素的血管降压作用的作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

References(11) Cited-By(1) Blood pressure responses to lycorenine were investigated in rats and dogs. Lycorenine (10-40 mg/kg p.o.) produced a decrease in blood pressure in conscious rats which was greater in hypertensive rats than in normotensive rats. In conscious dogs, lycorenine (5 or 10 mg/kg i.v.) produced rises in blood pressure and heart rate except for a few instances, while it produced a decrease in blood pressure in pentobarbital anesthetized dogs. Thus, there are species differences in cardiovascular effects of lycorenine between conscious rats and dogs. The development of tachyphylaxis to the vasodepressor actions of lycorenine and its related compounds was related to their alpha-adrenergic blocking activities at the time of the second injection in anesthetized rats. Desipramine which abolished or diminished the development of tachyphylaxis to the vasodepressor action of lycorenine (5 or 7.5 mg/kg i.v.), shortened the duration of its vasoderessor action and reduced its alpha-adrenergic blocking action. These results indicate that the development of tachyphylaxis to the vasodepressor action of lycorenine is ascribed to maintenance of its alpha-adrenergic blocking action.
机译:参考文献(11)被引用人(1)在大鼠和狗中调查了对lycorenine的血压反应。 Lycorenine(10-40 mg / kg p.o.)使清醒大鼠的血压下降比高血压大鼠的血压下降更大。在清醒的狗中,除少数情况外,lycorenine(5或10 mg / kg i.v.)使血压和心率升高,而在戊巴比妥麻醉的狗中使血压降低。因此,在清醒的大鼠和狗之间,lycorenine的心血管作用存在物种差异。速激肽对lycorenine及其相关化合物血管舒缩作用的发展与其在麻醉大鼠第二次注射时的α-肾上腺素阻断活性有关。地西拉明消除或减少了速溶对lycorenine(5或7.5 mg / kg i.v.)的血管舒缩作用的发展,缩短了其血管舒张作用的持续时间并降低了其对α-肾上腺素的阻断作用。这些结果表明,速激肽对lycorenine的血管舒缩作用的发展归因于其α-肾上腺素阻断作用的维持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号